Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Epsilon Healthcare Limited ( (AU:EPN) ) just unveiled an update.
Epsilon Healthcare Limited announced measures to reinforce its working capital position, including a $2,000,000 loan facility from its Managing Director, deferral of repayment deadlines for loans and fees owed to directors until 2027, and adjustment of obligations for management salaries and incentives. These actions, underscored by significant contributions from the leadership, reflect strong confidence in the company’s future prospects and enhance its financial stability to support ongoing operations and stakeholder interests.
The most recent analyst rating on (AU:EPN) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Epsilon Healthcare Limited stock, see the AU:EPN Stock Forecast page.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited (ASX: EPN) is an Australian-based, internationally active healthcare organization with a diversified and vertically integrated portfolio. The company specializes in healthcare and clinic operations, pharmaceutical contract development and manufacturing, along with pharmacy dispensing and information services.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.21M
Learn more about EPN stock on TipRanks’ Stock Analysis page.